A Case of Acute Myeloid Leukemia after Adalimumab Treatment in Psoriatic Arthritis
Journal of Rheumatic Diseases
;
: 91-94, 2012.
Artigo
em Inglês
| WPRIM
| ID: wpr-15488
ABSTRACT
Hematologic malignancies and lymphoproliferative disorders have been reported after using tumor necrosis factor-alpha inhibitor in patients suffering from spondyloarthropathy. Previously reported cases were treated by using infliximab and etanercept. Usually, it takes approximately several months for leukemia or lymphoproliferative disorders to occur after the application of those agents. However, we report a case of acute myeloid leukemia that developed after short term usage of adalimumab in a patient suffering from psoriatic arthritis.
Texto completo:
DisponíveL
Índice:
WPRIM (Pacífico Ocidental)
Assunto principal:
Estresse Psicológico
/
Imunoglobulina G
/
Leucemia Mieloide Aguda
/
Leucemia
/
Artrite Psoriásica
/
Fator de Necrose Tumoral alfa
/
Receptores do Fator de Necrose Tumoral
/
Neoplasias Hematológicas
/
Espondiloartropatias
/
Anticorpos Monoclonais Humanizados
Limite:
Humanos
Idioma:
Inglês
Revista:
Journal of Rheumatic Diseases
Ano de publicação:
2012
Tipo de documento:
Artigo
Similares
MEDLINE
...
LILACS
LIS